Coronavirus (COVID-19)

Mercyhealth Visitor Guidelines: Visitor guidelines have changed at some Mercyhealth locations. Please click here for the latest guidelines in place at our facilities. What to expect when... continue reading

Trials Available at Mercyhealth Cancer Care


NRG BR003– A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or without  Carboplatin for Node-Positive or High-Risk Node Negative Triple-Negative Invasive Breast Cancer

Alliance A011401 – Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer

Alliance A011502: A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial

Alliance A211601: Evaluation of Mammographic Breast Density Effect of Aspirin: A Companion to Alliance Study A011502

SWOG S1703: Randomized Non-Inferiority Trial Comparing Overall Survival of Patients Monitored with Serum Rumor Marker Directed Disease Monitoring (STMDDM) Versus Usual Care in Patients with Metastatic Hormone Receptor Positive Breast Cancer


Brain/Central Nervous System

No trials currently available.


Colon and Rectum

NRG GI004 – Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer



No trials currently available.



EA5163/S1709 INSIGNA: A Randomized, Phase III Study of Firstline Immunotherapy alone or in Combination with Chemotherapy in Induction/Maintenance or Postprogression in Advanced Nonsquamous Non?Small Cell Lung Cancer (NSCLC) with Immunobiomarker SIGNature?driven Analysis

LUNGMAP: A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously-Treated Non-Small Cell Lung Cancer (Lung-MAP Screening Study)


Mercyhealth Quality of Life Trial

SyMpTOM – Symptom Management Through Oncology Massage


Multiple Myeloma

No trials currently available.


Myelodysplastic Syndrome

No trials currently available.



No trials currently available.



No trials currently available.



No trials currently available.


Multiple Cancer Sites

EAY131 – Molecular Analysis for Therapy Choice (MATCH)

AMGEN: A Prospective observational Study to Estimate the Incidence of Febrile Neutropenia (FN) Among Subjects With Non-myeloid Malignancies at High Risk for FN and Receiving Neulasta (pegfilgrastim) Onpro Kit or Other Physician Choice Options for Prophylaxis of FN

Exact Sciences/ICONBlood Sample Collection to Evaluate Biomarkers in Subjects with Untreated Solid

Mercyhealth MyChart Sign In